Cancer news from the American Cancer Society.
Published on: July 26, 2024
A study of the HER2-targeted therapy drug trastuzumab deruxtecan (Enhertu) shows it can stop metastatic breast cancer growth for longer than chemotherapy.
Published on: June 13, 2024
A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain.
Published on: June 13, 2024
A study has shown that giving patients with lung cancer a targeted therapy drug after combined chemotherapy and radiation therapy helps them live longer without the cancer growing or spreading.